HC Wainwright & Co. Reiterates Buy on Ocular Therapeutix, Maintains $14 Price Target

Benzinga · 10/16 10:52
HC Wainwright & Co. analyst Yi Chen reiterates Ocular Therapeutix (NASDAQ:OCUL) with a Buy and maintains $14 price target.